Nature of changes in adrenocortical function in chronic hyperleptinemic female rats

Endocrine

Volumn 24, Issue 2, 2004, Pages 167-175

  Perelló, Mario ^a   Moreno, Griselda ^a   Camihort, Gisela ^b   Luna, Georgina ^b   Cónsole, Gloria ^b   Gaillard, Rolf C ^c   Spinedi, Eduardo ^a  

^a Instituto Multidisciplinario de Biologia Celular   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adiposity; Adrenal gland; ARC damage; Glucocorticoid; Hypothalamic obesity; Leptin; Ob Rb; Positive energetic balance

Indexed keywords

GLUTAMATE SODIUM; LEPTIN; CELL SURFACE RECEPTOR; CORTICOTROPIN; GLUCOCORTICOID; LEPTIN RECEPTOR; MESSENGER RNA;

ADRENAL CORTEX CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EVALUATION; FEMALE; HYPERLEPTINEMIA; HYPOTHALAMUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZONA FASCICULATA; ADRENAL CORTEX; ADRENAL GLAND; ANIMAL; ARCUATE NUCLEUS; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HYPERPLASIA; HYPOTHALAMUS DISEASE; NEWBORN; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADRENAL CORTEX; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; ARCUATE NUCLEUS; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HYPERPLASIA; HYPOTHALAMIC DISEASES; LEPTIN; OBESITY; RATS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SODIUM GLUTAMATE; ZONA FASCICULATA;

EID: 16644362237     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:24:2:167     Document Type: Article

References (40)

1. Nemeroff, C. B., Grant, L. D., Bissette, G., Erin, G. N., Harrell, L. E., and Prange, A. J. (1977). Psychoneuroendocrinology 2, 179-196.
2. Holzwarth-McBride, M. A., Sladek, J. R. Jr., and Knigge, K. M. (1976). Anat. Rec. 186, 197-205.
3. Krieger, D. T., Liotta, A. S., Nicholsen, G., and Kizer, J. S. (1979). Nature 278, 562-563.
4. Olney, J. W. and Sharpe, L. G. (1969). Science 166, 386-388.
5. Burde, R. M., Schainker, B., and Kayes, J. (1971). Nature 233, 58-60.
6. Redding, T. W., Schally, A. V., Arimura, A., and Wakabayashi, I. (1971). Neuroendocrinology 8, 245-255.
7. Larsen, P. J., Mikkelsen, J. D., Jessop, D., Lightman, S. L., and Chowdrey, H. S. (1994). J. Endocrinol. 141, 497-503.
8. Skultetyova, I., Kiss, A., and Jezova, D. (1998). Neuroendocrinology 67, 412-420.
9. Macho, L., Jezova, D., Zorad, S., and Fickova, M. (1999). Endocr. Regul. 33, 61-67.
10. Dolnikoff, M. S., Kater, C. E., Egami, M., de Andrade, I. S., and Marmo, M. R. (1988). Neuroendocrinology 48, 645-649.
11. Morris, M. J., Tortelli, C. F., Filippis, A., and Proietto, J. (1998). Regul. Pept. 75-76, 441-447.
12. Miller, R. J. and Dawson, G. (1979). In: Receptor for neurotransmitters and peptide hormones. Pepeu, G., Kuhar, M. J., and Enna, S. J. (eds.). Raven Press: New York.
13. DePaolo, L. V. and Negro-Vilar, A. (1982). Endocrinology 110, 835-841.
14. Spinedi, E., Johnston, C. A., and Negro-Vilar, A. (1984). Endocrinology 115, 267-272.
15. Badger, T. M., Millard, W. J., Martin, J. B., Rosenblum, P. M., and Levenson, S. E. (1982). Endocrinology 111, 2031-2038.
16. Bliss, E. L., Ailion, J., and Zwanziger, J. (1968). J. Pharmacol. Exp. Ther. 164, 122-134.
17. Palkovits, M., Brownstein, M., Kizer, J. S., Saavedra, J. M., and Kopin, I. J. (1976). Neuroendocrinology 22, 298-304.
18. Dawson, R., Pelleymounter, M. A., Millard, W. J., Liu, S., and Eppler, B. (1997). Am. J. Physiol. 273, E202-E206.
19. Spinedi, E. and Gaillard, R. C. (1998). Endocrinology 139, 4016-4020.
20. Hamann, A. and Matthaei, S. (1996). Exp. Clin. Endocrinol. Diabetes 104, 293-300.
21. Pralong, F. P., Roduit, R., Waeber, G., et al. (1998). Endocrinology 139, 4264-4268.
22. Kaneko, M., Hiroshige, T., Shinsako, J., and Dallman, M. F. (1980). Am. J. Physiol. 239, R309-R316.
23. Olney, J. W. (1969). Science 164, 719-721.
24. Cowley, M. A., Smart, J. L., Rubinstein, M., et al. (2001). Nature 411, 480-484.
25. Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., and Kalra, P. S. (1999). Endocr. Rev. 20, 68-100.
26. Holsboer, F. and Barden, N. (1996). Endocr. Rev. 17, 187-205.
27. Heiman, M. L., Ahima, R. S., Craft, L. S., Schoner, B., Stephens, T. W., and Flier, J. S. (1997). Endocrinology 138, 3859-3863.
28. Giovambattista, A., Chisari, A. N., Gaillard, R. C., and Spinedi, E. (2000). Neuroendocrinology 72, 341-349.
29. Tena-Sempere, M., Pinilla, L., Gonzalez, L. C., Casanueva, F. F., Dieguez, C., and Aguilar, E. (2000). J. Endocrinol. 167, 479-486.
30. Sahu, A. (2003). Front. Neuroendocrinol. 24, 225-253.
31. Sahu, A. (2004). Endocrinology 144, 3789-3798.
32. Perello, A., Gaillard, R.C., Chisari, A. N., and Spinedi, E. (2003). Neuroendocrinology 78, 176-184.
33. Daneva, T., Spinedi, E., Hadid, R., and Gaillard, R. C. (1995). Neuroendocrinology 62, 79-86.
34. Spinedi, E., Aguado, L., Basilotta, G., and Carrizo, D. (1989). J. Endocrinol. Invest. 12, 321-327.
35. Cónsole, G. M., Jurado, S. B., Petruccelli. M., Carino, M., Calandra, R. S., and Gómez Dumm, C. L. A. (2002). Neuroendocrinology 75, 316-325.
36. Spinedi, E., Giacomini, M., Jacquier, M. C., and Gaillard, R. C. (1991). Neuroendocrinology 53, 160-170.
37. Chomczynski, P. and Sacchi, N. (1987). Anal. Biochem. 162, 156-159.
38. Giovambattista, A., Chisari, A. N., Corro, L., Gaillard, R. C., and Spinedi, E. (2000). Neuroimmunomodulation 7, 92-98.
39. Spinedi, E. and Negro-Vilar, A. (1984). Endocrinology 114, 2247-2251.
40. McElroy, W. D., and Swanson, C. P. (eds.) (1974). Biostatistical analysis. Prentice-Hall: Englewood Cliffs, N.J.